Great article released today in Bioshares publication, there is a link on the BOD website.
Human trials beginning - Another BOD milestone
Research article talked about recent takeover activity in BioMD's airspace with large pharmacueticals buying into the tissue implant sector. Forecast growth of this sector wordwide is huge and BOD has a big part to play.
Article also remarked that there was quite probably sufficient data already tested by BOD to move straight to the liscensing and commercialisation stage.
BOD has already signalled that it is in discussions with major industry players.
Still as cheap as bananas hey Monkeyman
Let the good times roll
BOD Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held